A Phase 3b, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.
Phase of Trial: Phase III
Latest Information Update: 08 Jun 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Sponsors Ipsen
- 08 Jun 2017 Primary endpoint (Change from baseline in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total score) has been met, according to the results presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
- 08 Jun 2017 Results presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
- 17 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.